MURRAY, Utah, June 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, today announced that it has granted equity awards under the R1 RCM Inc. 2022 Inducement Plan (the “Inducement Plan”) in connection with its acquisition of Cloudmed, which closed today.
R1 Announces Grants of Inducement Equity Awards in Connection with the Acquisition of Cloudmed
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.